Clinical Trials · NCT05281328
A Trial to Assess the Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With PLD
- Phase
- Phase 2/Phase 3
- Recruitment status
- Active Not Recruiting
- Sponsor
- Camurus AB
- Enrollment
- 71
- Start date
- Jun 2022
- Locations
- 11 sites, 4 countries
- Primary endpoint
- Height-adjusted Total Liver Volume (htTLV)